Accelerate drug discovery by automating candidate screening and scientific evaluation.
What is Convexia?
Convexia: Accelerate drug discovery by automating candidate screening and scientific evaluation. Paid, from $199/mo. Zekai scores it 7.5 out of 10 after independent testing. Best for automating drug diligence and candidate screening.
Zekai Verdict
- What is it?
- Convexia offers an integrated AI solution for pharmaceutical R&D, automating drug diligence and candidate screening.
- Best for
- Drug Discovery Scientists and Preclinical Project Managers benefit most from Convexia, as it automates the initial…
- Price
- $199/mo
- Zekai Score
- 7.5/10
Schrödinger
Insilico Medicine
Blank Bio
RecursionFor pharmaceutical and biotech R&D, Convexia is a leading AI solution for automating drug diligence and candidate screening. It replaces time-intensive manual evaluations with an end-to-end AI stack. This platform accelerates early discovery by scanning millions of global drug candidates, allowing expert resources to focus on advancing the most promising therapeutic assets.
Try it with these prompts
Copy any prompt and paste it directly into the tool.
Scan the globe for overlooked drug assets, from preclinical biotech to abandoned pharma IP. Our AI pulls structured and unstructured data to find high-potential candidates.
Run deep in silico simulations using over 50 custom-tuned models to assess binding, toxicity, ADME/PK, immunogenicity, and mechanistic fit.
Uncover market signals like unmet need, competitive landscape, and IP positioning. Model operational risks using digital twin simulations to score execution risk before trials start, flagging trial fragility.
Prompts for Pharma
Trusted by professionals
Best Convexia alternatives
Convexia vs BenevolentAI: Convexia focuses specifically on automating drug diligence and candidate screening with an end-to-end AI stack. This makes it ideal for teams looking to accelerate early discovery and preclinical assessment by replacing manual evaluations. In contrast, BenevolentAI offers a broader, more comprehensive platform that spans the entire drug discovery and development process, from target identification to clinical trial design. While BenevolentAI provides a wider scope, Convexia’s specialized approach offers a targeted solution for organizations aiming to optimize the efficiency of their initial R&D phases, rapidly filtering through millions of potential therapeutic assets.
Is Convexia worth it?
Why Pharmaceutical & Biotech choose this tool
Key Use Cases
Frequently asked questions
Does Convexia offer a free trial?
What is the best use of Convexia for Pharmaceutical R&D professionals?
What integrations does Convexia offer?
How does Convexia provide value for money in Pharmaceutical R&D?
Convexia pricing and plans
Prices and features are updated regularly but can change at any time — always confirm on the official website. Some links on this page are affiliate links.
Top 10 AI tools in this category
Take it with you
- What is Convexia?
- How it accelerates drug diligence.
- Integrating with your R&D workflow.
- Defining screening parameters.
- Inputting therapeutic targets.
Get Convexia deal alerts
Be the first to know when Convexia drops a new discount, adds features, or changes pricing.
More on AI for Pharmaceutical & Biotech
Latest AI news
About Convexia
Full Description
Convexia offers an integrated AI solution for pharmaceutical R&D, automating drug diligence and candidate screening. It supports professionals advancing therapeutic assets by replacing manual evaluations with an end-to-end AI stack. This platform accelerates early discovery and preclinical assessment by scanning millions of global drug candidates.
